Massive empyema caused by Mycoplasma pneumoniae in an adult: A case report

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Shuvy, Mony ^a   Rav Acha, Moshe ^a   Izhar, Uzi ^a   Ron, Merav ^a   Nir Paz, Ran ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIINFLAMMATORY AGENT; AZITHROMYCIN; BACTERIAL DNA; C REACTIVE PROTEIN; CEFUROXIME; ROXITHROMYCIN; STREPTOKINASE; ANTIINFECTIVE AGENT;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ATELECTASIS; BACTERIUM DETECTION; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; DECORTICATION; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; EMPYEMA; ERYTHROCYTE SEDIMENTATION RATE; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LEUKOCYTOSIS; LUNG SURGERY; MYCOPLASMA PNEUMONIAE; NONHUMAN; PERICARDITIS; PLEURA EFFUSION; PLEURAL PAIN; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; THORACOTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; MICROBIOLOGY; MIDDLE AGED; MYCOPLASMA PNEUMONIA; PATHOLOGY; PHYSIOLOGY; PLEURA EMPYEMA;

ANTI-BACTERIAL AGENTS; EMPYEMA, PLEURAL; FEMALE; HUMANS; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA;

EID: 33644914747     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-18     Document Type: Article

References (13)

1. Waites KB, Talkington DF: Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004, 17(4):697-728, table of contents.
2. Daxboeck F, Krause R, Wenisch C: Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003, 9(4):263-273.
3. Loens K, Ursi D, Goossens H, Ieven M: Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol 2003, 41(11):4915-4923.
4. van Kuppeveld FJ, van der Logt JT, Angulo AF, van Zoest MJ, Quint WG, Niesters HG, Galama JM, Melchers WJ: Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl Environ Microbiol 1992, 58(8):2606-2615.
5. Abele-Horn M, Busch U, Nitschko H, Jacobs E, Bax P, Pfaff F, Schaffer B, Heesemann J: Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol 1998, 36(2):548-551.
6. de Barbeyrac B, Bernet-Poggi C, Febrer F, Renaudin H, Dupon M, Bebear C: Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction. Clin Infect Dis 1993, 17 Suppl 1:S83-9.
7. Fine NL, Smith LR, Sheedy PF: Frequency of pleural effusions in mycoplasma and viral pneumonias. N Engl J Med 1970, 283(15):790-793.
8. Narita M, Matsuzono Y, Itakura O, Yamada S, Togashi T: Analysis of mycoplasmal pleural effusion by the polymerase chain reaction. Arch Dis Child 1998, 78(1):67-69.
9. Narita M, Tanaka H: Two Distinct Patterns of Pleural Effusions Caused by Mycoplasma pneumoniae Infection. Pediatr Infect Dis J 2004, 23(11):1069.
10. Wang RS, Wang SY, Hsieh KS, Chiou YH, Huang IF, Cheng MF, Chiou CC: Necrotizing pneumonitis caused by Mycoplasma pneumoniae in pediatric patients: report of five cases and review of literature. Pediatr Infect Dis J 2004, 23(6):564-567.
11. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T: Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin Diagn Lab Immunol 2000, 7(6):909-914.
12. Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, Abe S: Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest 2002, 121(5):1493-1497.
13. Daxboeck F, Kircher K, Krause R, Heinzl H, Wenisch C, Stanek G: Effect of age on antibody titer to Mycoplasma pneumoniae. Scand J Infect Dis 2002, 34(8):577-579.